Hawaii to receive $800k of $71M settlement with drugmaker Amgen

Hawaii will receive $800,000 as part of a $71 million multi-state settlement with Amgen Inc. over the marketing claims about the drugs Aranesp and Enbrel. The state will share the settlement with 47 other states and the District of Columbia, officials with the state Department of Commerce and Consumer Affairs’ Office of Consumer Protection said. The allegations against Amgen Inc. (Nasdaq: AMGN) involve accusations that Amgen promoted Aranesp, which is use to treat anemia, for dosing frequencies…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Source Type: news